80 results
424B5
ENVB
Enveric Biosciences Inc
3 May 24
Prospectus supplement for primary offering
5:05pm
University of London
Clinical Research
John Krystal, M.D.
Director of Yale Center for Clinical Investigation
Clinical Research
Michael Liebowitz, M.D
8-K
EX-10.1
ENVB
Enveric Biosciences Inc
3 May 24
Entry into a Material Definitive Agreement
5:04pm
Reports, there is no suit, action, proceeding or investigation pending or, to the Company’s knowledge, threatened against the Company (or any affiliate … , costs and expenses, including all judgments, amounts paid in settlements, court costs and attorneys’ fees and costs of investigation, that any
424B5
ENVB
Enveric Biosciences Inc
11 Mar 24
Prospectus supplement for primary offering
12:35pm
of RIFFIT, Inc.; Professor, St. George’s University of London
Clinical Research
John Krystal, M.D.
Director of Yale Center for Clinical Investigation
8-K
EX-10.1
4k3qq1w
11 Mar 24
Entry into a Material Definitive Agreement
8:00am
8-K
EX-4.1
4rsk1c
29 Dec 23
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
h36tvk
6 Nov 23
Entry into a Material Definitive Agreement
8:05am
8-K
EX-10.2
y5y ks88w8fa1j
6 Nov 23
Entry into a Material Definitive Agreement
8:05am
8-K
EX-5.1
uh5hdzw0 by
1 Sep 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-1.1
x1u2f oxeeis21o5
1 Sep 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-10.3
0nq8guo iq38xn
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
EX-10.1
o29ubo
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
EX-10.2
xc1q5okf6icu5wloa
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
EX-99.1
qua6kjkv d1ewh
19 Jul 22
Enveric Biosciences Announces Formation of Scientific Advisory Board to Drive Further Growth of Next-Generation Mental Health Medicines
8:25am